Summary
Clinical trials for binary therapies, like boron neutron capture therapy (BNCT), pose a number of unique problems and challenges in design, performance, and interpretation of results. In neutron beam development, different groups use different optimization parameters, resulting in beams being considerably different from each other. The design, development, testing, execution of patient pharmacokinetics and the evaluation of results from these studies differ widely. Finally, the clinical trials involving patient treatments vary in many aspects such as their dose escalation strategies, treatment planning methodologies, and the reporting of data. The implications of these differences in the data accrued from these trials are discussed. The BNCT community needs to standardize each aspect of the design, implementation, and reporting of clinical trials so that the data can be used meaningfully.
Similar content being viewed by others
References
Locher GL: Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol 36: 1–13, 1936
Gahbauer R, Gupta N, Blue T, Goodman J, Barth R, Grecula J, Soloway AH, Sauerwein W, Wambersie A: Boron neutron capture therapy: principles and potential. Recent Results Cancer Res 150: 183–209, 1998
Barth RF, Soloway AH, Brugger RM: Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Invest 14: 534–550, 1996
Slatkin DN: A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit. Brain 114: 1609–1629, 1991
Hatanaka H, Nakagawa Y: Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28: 1061–1066, 1994
Diaz AZ, Chanana AD, Coderre JA, Ma R: Retrospective review of the clinical BNCT trial at Brookhaven National Laboratory. In: Proceedings of the Ninth International Symposium on Neutron Capture Therapy for Cancer, Osaka, Japan, 2000, pp 13–14
Busse P, Harling OK, Palmer MR, Kaplan I, Newton TH, Kaplan J, Chuang C, Kiger III WS, Riley K, Goorley JT, Zamenhof RG: A phase-I clinical trial for cranial BNCT at Harvard-MIT. In: Proceedings of the Ninth International Symposium on Neutron Capture Therapy for Cancer, Osaka, Japan, 2000, pp 27–28
Sauerwein W, Hideghety K, Abbe JC, de Vries M, Gotz C, Paquis P, Grochulla F, Heimans J, Haselsberger K, Turowski K, Moss RL, Rassow J, Stecher-Rasmussen F, Touw D, Wiestler OD, Frankhausr H, Gabel D: Preliminary clinical results from the EORTC 11916 trial at the Petten irradiation facility. In: Proceedings of the Ninth International Symposium on Neutron Capture Therapy for Cancer, Osaka, Japan 2000, pp 15–16
Savolainen S, Auterinen I, Kallio M, Karkkainen M, Kosunen A, Aschan C, Benczik J, Farkkila M, Hiismaki P, Kaita K, Kulvik M, Ryynanen P, Seppala T, Seren T, Tanner V, Toivonen M, Vahatalo J, Yla-Mella H: The Finnish boron neutron capture therapy program — an overview of scientific projects. In: Larsson B, Crawford J, Weinreich RI (eds) Advances in Neutron Capture Therapy vol I, Medicine and Physics, Elsevier, Amsterdam, 1997, pp 342–347
Skold K, Kierkegaard J, Gudowska I, Hakansson R, Capala J: The swedish facility for boron neutron capture therapy. In: Proceedings of the Ninth International Symposium on Neutron Capture Therapy for Cancer, Osaka, Japan, 2000, pp 39–40
Marek M, Viererbl L, Flibor S, Burian J, Rejchrt J: Validation of epithermal neutron beam at LVR-15. In: Proceedings of the Ninth International Symposium on ‘Neutron Capture Therapy for Cancer’, Osaka, Japan, 2000, pp 41–42
Laramore GE, Wootton P, Livesey JC, Wilbur DS, Risler R, Phillips M, Jacky J, Buchholz TA, Griffin TW, Brossard S: Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy. Int J Radiat Oncol Biol Phys 28: 1135–1142, 1994
Sauerwein W, Ziegler W, Olthoff K, Streffer C, Rassow J, Sack H: Neutron capture therapy using a fast neutron beam: clinical considerations & physical aspects. Strahlentherapie und Onkologie 165: 208–210, 1989
Waterman FM, Kuchnir FT, Skagg LS, Bewley DK, Page BC, Attix FH: The use of B-10 to enhance the tumor dose in fast neutron therapy. Phys Med Biol 23: 592–602, 1978
Gahbauer R, Goodman J, Blue T: Some thoughts on tolerance, dose, and fractionation in boron neutron capture therapy. Basic Life Sciences 50: 81–85, 1989
Gupta N, Gahbauer RA, Blue TE, Wambersie A: Dose prescription in boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28: 1157–1166, 1994
Kramer S: Tumor extent as a determining factor in radiotherapy of glioblastomas. Acta Rad Therapy, Phys Biol 8: 111–117, 1969
Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907–911, 1980
Laramore G, Diener-West M, Griffin T, Nelson J, Griem M, Thomas FJ, Handrikson F, Griffen B, Myrianthopoulos L, Saxton J: Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Int J Radiat Oncol Biol Phys 14: 1093–1102, 1988
Schulz-Ertner D, Haberer T, Jakel O, Thilmann C, Kramer M, Enghardt W, Kraft G, Wannenmacher M, Debus J: Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbonions. Int J Radiat Oncol Biol Phys 53: 36–42, 2002
Debus J, Haberer T, Schulz-Ertner D, Jakel O, Wenz F, Enghardt W, Schlegel W, Kraft G, Wannenmacher M: Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives. Strahlenther Onkol 176: 211–216, 2000
Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, Lamborn K, Wilson CB, Phillips TL, Larson DA: Phase III trial of accelerated hyperfractionation with or without Difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 49: 71–77, 2001
McDermott MW, Sneed PK, Gutin PH: Interstitial brachytherapy for malignant brain tumors. Seminars Surgical Oncol 14: 79–87, 1998
Castro JR, Phillips TL, Prados M, Gutin P, Larson DA, Petti PL, Daftari IK, Collier JM, Lillis-Hearne P: Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys 38: 257–261, 1997
Sneed PK, McDermott MW, Gutin PH: Interstitial brachytherapy procedures for brain tumors. Seminars Surgical Oncol 13: 157–166, 1997
Sneed PK, Lamborn KR, Larson DA, Prados MD, Malec MK, McDermott MW, Weaver KA, Phillips TL, Wara WM, Gutin PH: Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 35: 37–44, 1996
Barker FG, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK, McDermott MW, Sneed PK, Wara WM, Wilson CB: Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 84: 442–448, 1996
Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH: Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Int J Radiat Oncol Biol Phys 47: 209–218, 2000
Barth RF, Yang W, Bartus RT, Rotaru JH, Ferketich AK, Moeschberger ML, Nawrocky MM, Coderre JA, Rofstad EK: Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine. Int J Radiat Oncol Biol Phys 52: 858–868, 2002
Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA: Combination of boron neutron capture therapy and external beam x-irradiation for the treatment of brain tumors. In: Sauerwein W, Moss R, Wittig A (eds) Research and Development in Neutron Capture Therapy, Proceedings of the 10th International Congress on Neutron Capture Therapy, Essen, Germany, September 8–13, 2002. Monduzzi Editore, S.p.A International Proceedings Division. Bologna, Italy, 2002, pp 733–737
Gahbauer R, Gupta N, Blue T, Goodman J, Barth R, Grecula J, Soloway AH, Sauerwein W, Wambersie A: Fast neutrons and high-LET particles in cancer therapy. In: Englehart-Cabillic A, Wambersie A (eds) Boron Neutron Capture Therapy: Principles and Potential. Heidelberg, Springer-Verlag Berlin, (150), 1998, pp 183–209
Gierga DP, Yanch JC, Shefer RE: Development and construction of a neutron beam line for accelerator-based boron neutron capture synovectomy. Med Phys 27: 203–214, 2000
Nigg DW, Wemple CA, Risler R, Hartwell JK, Harker YD, Laramore GE: Modification of the University of Washington neutron radiotherapy facility for optimization of neutron capture enhanced fast-neutron therapy. Med Phys 27: 359–367, 2000
Zamenhof RG, Clement SD, Harling OK, Brenner JF, Wazer DE, Madoc-Jones H, Yanch JC: Monte Carlo based dosimetry and treatment planning for neutron capture therapy of brain tumors. Basic Life Sci 54: 283–305, 1990
Woollard JE, Albertson BJ, Reed MK, Blue TE, Capala J, Gupta N, Gahbauer RA: A comparison of neutron beams for BNCT based on in-phantom neutron field assessment parameters. Med Phys 28: 184–193, 2001
Gabel D, Foster S, Fairchild RG: The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Rad Res 111: 14–25, 1987
Zamenhof RG, Patel H, Palmer MR, Harling O, Binns PJ, Riley K, Bernard J, Lin H-C, Busse P: A core laboratory offering full evaluation of new boron compounds: a service to the BNCT community. In: Proceedings of the Ninth International Symposium on Neutron Capture Therapy for Cancer, Osaka, Japan, October 2000, pp 65–66
Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC: Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery 47: 608–621, 2000
Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Wielopolski L, Chanana AD: Boron Neutron-Capture Therapy (BNCT) for Glioblastoma Multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. Int J Radiat Oncol Biol Phys 40: 829–834, 1998
Ceberg CP, Persson A, Brun A, Huiskamp R, Fyhr AS, Persson BR, Salford LG: Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron neutron capture therapy. J Neurosurg 83: 79–85, 1995
Gabel D, Preusse D, Haritz D, Grochulla F, Haselsberger K, Fankhauser H, Ceberg C, Peters HD, Klotz U: Pharmacokinetics of Na2B 12H1 1SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture. Acta Neurochir 139: 606–611, 1997
Stragliotto G, Fankhauser H: Biodistribution of boron sulfhydryl for boron neutron capture therapy inpatients with intracranial tumors. Neurosurgery 36: 285–292, 1995
Gavin PR, Kraft SL, Huiskamp R, Coderre JA: A review: CNS effects and normal tissue tolerance in dogs. J Neuro-Oncol 33: 71–80, 1997
Gabel D, Philipp KH, Wheeler FJ, Huiskamp R: The compound factor of the 10B(n,alpha)7Li reaction from borocaptate sodium and the relative biological effectiveness of recoil protons for induction of brain damage in boron neutron capture therapy. Rad Res 149: 378–386, 1998
Wheeler FJ: Microdosimetric calculations for boron-drug compound factors for boron neutron capture therapy. Trans Am Nucl Soc 65: 147, 1992
Zamenhof RG: Microdosimetry for boron neutron capture therapy: a review. J Neuro-Oncol 33: 81–92, 1997
Hopewell J: Personal Communication
Harling OK, Moulin D, Chabeuf JM, Solares GR: On-Line Beam Monitoring for Boron Neutron Capture Therapy at the MIT Research Reactor. In: Mishima Y (ed) Proceedings of the Sixth International Symposium of Neutron Capture Therapy, Plenum Press, New York, 1996, pp 261–269
Raaijmakers CP, Konijnenberg MW, Verhagen HW, Mijnheer BJ: Determination of dose components in phantoms irradiated with an epithermal neutron beam for boron neutron capture therapy. Med Phys 22: 321–329, 1995
Kobayashi T, Kanda K: Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry. Nucl Instr Meth 204: 96–103, 1983
Woollard JE, Blue TE, Curran JF, Dobelbower MC, Busby HR: An alpha autoradiographic technique for spatial quantification of boron-10 concentrations in tissue. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 110: 96–103, 1992
Solares GR, Zamenhof RG: A novel approach to the micro-dosimetry of neutron capture therapy. Part I. High-resolution quantitative autoradiography applied to microdosimetry in neutron capture therapy. Rad Res 144: 50–58, 1995
Barth RF, Adams DM, Soloway AH, Mechetner EB, Alam F, Anisuzzaman AK: Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. Analytical Chem 63: 890–893, 1991
ICRU: ICRU Report 33: Radiation Quantities and Units. (ICRU Report 33), International Commission on Radiation Units and Measurements, Washington DC, 1980
Nigg DW, Wheeler FJ, Wessol DE, Capala J, Chadha M: Computational dosimetry and treatment planning for boron neutron capture therapy. J Neuro-Oncol 33: 93–104, 1997
Zamenhof R, Redmond E, Solares G, Katz D, Riley K, Kiger S, Harling OK: Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data. Int J Radiat Oncol Biol Phys 35: 383–397, 1996
Reinstein LE, Ramsay EB, Gajewski J, Rammamoorthy S, Meek AG: SBNCT-PLAN: A 3-dimensional treatment planning system for boron neutron capture therapy. Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York, 1993, pp 171–175
Nigg DW, Randolph PD, Wheeler FJ: Demonstration of three-dimensional deterministic radiation transport theory dose distribution analysis for boron neutron capture therapy. Med Phys 18: 43–53, 1991
Goorley JT, Kiger WS III, Zamenhof RG: Reference dosimetry calculations for neutron capture therapy with comparison of analytical and voxel models. Med Phys 129: 145–156, 2002
Hall EJ: Radiobiology for the Radiologist. 4th edn., J. B. Lippincott Company, Philadelphia, 1994
Hideghety K, Sauerwein W, Haselsberger K, Grochulla F, Fankhauser H, Moss R, Huiskamp R, Gabel D, de VM: Post-operative treatment of glioblastoma with BNCT at the petten irradiation facility (EORTC protocol 11,961). Strahlenther Onkol 175 (Suppl 2): 111–114, 1999
Elowitz EH, Bergland RM, Coderre JA, Joel DD, Chadha M, Chanana AD: Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. Neurosurgery 42: 463–468, 1998
Rassow J, Stecher-Rasmussen F, Voorbraak W, Moss R, Vroegindeweij C, Hideghety K, Sauerwein W: Comparison of quality assurance for performance and safety characteristics of the facility for Boron Neutron Capture therapy in Petten/NL with medical electron accelerators. Radiotherapy Oncol 59: 99–108, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, N., Gahbauer, R.A., Blue, T.E. et al. Common challenges and problems in clinical trials of boron neutron capture therapy of brain tumors. J Neuro-Oncol 62, 197–210 (2003). https://doi.org/10.1007/BF02699945
Issue Date:
DOI: https://doi.org/10.1007/BF02699945